Gilenya (Fingolimod) Capsule, 0.5MG


Indications and Reactions:

Role Indications Reactions
Primary
Multiple Sclerosis 91.5%
Relapsing-remitting Multiple Sclerosis 7.6%
Multiple Sclerosis Relapse 0.3%
Gait Disturbance 0.1%
Immunisation 0.1%
Pain 0.1%
Primary Progressive Multiple Sclerosis 0.1%
Secondary Progressive Multiple Sclerosis 0.1%
Fatigue 12.2%
Somnolence 7.9%
Nausea 7.6%
Heart Rate Decreased 6.4%
Visual Impairment 6.1%
White Blood Cell Count Decreased 6.1%
Vision Blurred 5.9%
Memory Impairment 5.1%
Herpes Zoster 4.8%
Paraesthesia 4.3%
No Adverse Event 4.1%
Pain In Extremity 4.1%
Pain 3.3%
Pyrexia 3.3%
Rash 3.3%
Tremor 3.3%
Malaise 3.1%
Nasopharyngitis 3.1%
Visual Acuity Reduced 3.1%
Vomiting 3.1%

Drug Data